Close this search box.

New genomics research delivers sustainable solutions to public health, environmental and food security challenges


Genome Canada funding supports cutting-edge genomics research and development projects with real-world impact for Canadians

Genomics technologies and innovations are crucial to finding solutions to global challenges such as climate change, environmental protection, precision health, and food and energy security.

Today, the Minister of Innovation, Science and Industry, François-Philippe Champagne, announced more than $17 million in federal support to eight new genomics research projects and four technology platforms funded through Genome Canada. Provincial governments, businesses and research partners are investing almost $24 million in co-funding, for a total investment of over $41 million.

The eight projects announced today, part of Genome Canada’s Genomic Applications Partnership Program (GAPP), will harness cutting-edge genomics science and innovative technologies and tools to deliver real-world impacts for Canadians and drive healthier, more sustainable and prosperous communities across Canada. GAPP leverages world-leading expertise and diversified public-private partnerships to accelerate the adoption of genomics solutions to generate broad economic and societal benefits for Canada.

These public-private partnerships will generate solutions for:

Health, by:

  • reducing transplant patients’ risk of organ rejection by better matching donors and recipients;
  • accelerating fungal drug discovery;
  • improving diagnosis times and accuracy for sarcoma patients and for those with inherited mismatch repair disorder who have an increased risk of developing advanced cancers;
  • using therapeutic cord blood-derived natural killer cells for hard-to-treat cancers; and
  • improving IVF outcomes through whole-genome sequencing of embryos.

The environment, by integrating citizen science into video games to enhance understanding of biodiversity and antimicrobial resistance genes.

Resilient agriculture, by providing a sustainable secure domestic supply of bees for honey production and pollination of agricultural crops.

The four technology platform investments support genomics technology infrastructure at facilities and networks across Canada to provide researchers access to leading-edge genomics technologies. In collaboration with the Canada Foundation for Innovation (CFI) Major Science Initiative (MSI) 2023-29 competition, Genome Canada is investing in four facilities: CGEn, The Metabolomics Innovation Centre, Centre for Biodiversity Genomics and GlycoNet.


“Canadian researchers, entrepreneurs, and companies are the driving force of progress that brings scientific discovery to the market. Investments in programs like Genome Canada’s Genomic Application Partnership Program boost research and innovation to strengthen Canada’s genomics capacity. It also ensures that Canadian researchers and businesses continue to solve some of the world’s most pressing challenges and remain world leaders in science and new technologies.”

– The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry

The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry

“Genome Canada and the Government of Canada continue to work together to drive and deliver high-impact genomics research and innovation collaborations that accelerate the translation of scientific knowledge into broad economic and societal benefits for Canada. We also continue to strategically invest federal funds in advanced technology and research services development. By invigorating and enhancing research services and commercial applications, these facilities ensure a robust pipeline of innovative, made-in-Canada solutions.”

– Dr. Rob Annan, President and CEO, Genome Canada

Dr. Rob Annan, President and CEO, Genome Canada

Learn more about the 12 projects announced today:

Quick facts

  • Genome Canada’s Genomic Applications Partnership Program (GAPP) is a flagship initiative that marked its 10th year and 100th funded project in 2023.
    • Within GAPP, today’s announcement includes more than $11 million in federal funding for genomics research and an additional $23 million in co-funding from provincial governments, businesses and other research partners across Canada, for a total investment of $34 million in this flagship program.
  • Genome Canada’s support for national genomics infrastructure is vital to strengthening Canada’s genomics capacity and a key driver of our impact.
    • Today’s announcement includes nearly $6 million in federal funding, plus $800,000 in co-funding from other research partners, for a total investment of nearly $7 million.
  • Budget 2021 provided $400 million over six years, starting in 2021–22, to support the creation of the Canadian Genomics Strategy to drive further innovation in genomics through commercialization and adoption. This funding included $136.7 million over five years, starting in 2022–23, for programming delivered by Genome Canada to kick-start the new strategy and complement existing genomics research and innovation programming.
  • Since 2000, Genome Canada invested $1.6 billion in federal investment and leveraged $2.4 billion in co-funding, for a total investment of $4.0 billion in R&D, supported 13,782 talented research trainees, and spun-out 120 new Canadian companies.

Media contact

Nicola Katz
Director, Communications
Genome Canada
Cell: 613-297-0267